Search
27/12/2022
Real-world effectiveness of caplacizumab vs the standard of care in immune thrombotic thrombocytopenic purpura
Izquierdo, CP, Mingot-Castellano, ME, Fuentes, AEK, Peinado, JGA, Cid, J, Jimenez, MM, Valcarcel, D, Gomez-Segui, I, de la Rubia, J, Martin, P, Goterris, R, Hernandez, L, Tallon, I, Varea, S, Fernandez, M, Garcia-Munoz, N, Vara, M, Zarzoso, MF, Garcia-Candel, F, Paciello, ML, Garcia-Garcia, I, Zalba, S, Campuzano, V, Gala, JM, Estevez, JV, Jimenez, GM, Lorenzo, JLL, Arias, EG, Freiria, C, Sole, M, Idrovo, LFA, Castellet, JCH, Cruz, N, Lavilla, E, PTrez-Montana, A, Atucha, JA, Beltran, MEM, Macias, JRM, Salinas, R, del Rio-Garma, J. Real-world effectiveness of caplacizumab vs the standard of care in immune thrombotic thrombocytopenic purpura. Blood Advances. 2022; 6(24)DOI:10.1182/bloodadvances.2022008028. PMID:35930694. IF:7.500(Q1/2D).
27/12/2022
Case report: Challenges in immune reconstitution following hematopoietic stem cell transplantation for CTLA-4 insufficiency-like primary immune regulatory disorders
Margarit-Soler, A, Deya-Martinez, A, Canizales, JT, Vlagea, A, Garcia-Garcia, A, Marsal, J, Del Castillo, MT, Planas, S, Simo, S, Esteve-Sole, A, Grande, MSL, Badell, I, Tarrats, MR, Fernandez-Aviles, F, Alsina, L. Case report: Challenges in immune reconstitution following hematopoietic stem cell transplantation for CTLA-4 insufficiency-like primary immune regulatory disorders. Frontiers in Immunology. 2022; 13DOI:10.3389/fimmu.2022.1070068. PMID:36636328. IF:7.300(Q1/3D).
27/12/2022
Acute LDL-C reduction post ACS: strike early and strike strong: from evidence to clinical practice. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Association of Preventive Cardiology (EAPC) and the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Krychtiuk, KA, Ahrens, I, Drexel, H, Halvorsen, S, Hassager, C, Huber, K, Kurpas, D, Niessner, A, Schiele, F, Semb, AG, Sionis, A, Claeys, MJ, Barrabes, J, Montero, S, Sinnaeve, P, Pedretti, R, Catapano, A. Acute LDL-C reduction post ACS: strike early and strike strong: from evidence to clinical practice. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Association of Preventive Cardiology (EAPC) and the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. European Heart Journal-Acute Cardiovascular Care. 2022; 11(12)DOI:10.1093/ehjacc/zuac123. PMID:36574353. IF:4.100(Q2/4D).
26/12/2022
Lack of sex-related analysis and reporting in Cochrane Reviews: a cross-sectional study
Antequera, A, Cuadrado-Conde, MA, Roy-Vallejo, E, Montoya-Martinez, M, Leon-Garcia, M, Madrid-Pascual, O, Calderon-Larranaga, S. Lack of sex-related analysis and reporting in Cochrane Reviews: a cross-sectional study. Systematic Reviews. 2022; 11(1)DOI:10.1186/s13643-021-01867-3. PMID:36572932. IF:3.700(Q2/4D).
26/12/2022
Diverse monogenic subforms of human spermatogenic failure
Nagirnaja, L, Lopes, AM, Charng, WL, Miller, B, Stakaitis, R, Golubickaite, I, Stendahl, A, Luan, TPC, Friedrich, C, Mahyari, E, Fadial, E, Kasak, L, Vigh-Conrad, K, Oud, MS, Xavier, MJ, Cheers, SR, James, ER, Guo, JT, Jenkins, TG, Riera-Escamilla, A, Barros, A, Carvalho, F, Fernandes, S, Goncalves, J, Gurnett, CA, Jorgensen, N, Jezek, D, Jungheim, ES, Kliesch, S, McLachlan, RI, Omurtag, KR, Pilatz, A, Sandlow, J, Smith, J, Eisenberg, ML, Hotaling, JM, Jarvi, KA, Punab, M, Rajpert-De Meyts, E, Carrell, DT, Krausz, C, Laan, M, O'Bryan, MK, Schlegel, PN, Tuttelmann, F, Veltman, JA, Almstrup, K, Aston, KI, Conrad, DF. Diverse monogenic subforms of human spermatogenic failure. Nature Communications. 2022; 13(1)DOI:10.1038/s41467-022-35661-z. PMID:36572685. IF:16.600(Q1/1D).
16/12/2022
Editorial: Genotype-phenotype correlations in neurodegenerative diseases: From clinical features to neuroimaging signatures
Ferraro, PM, Spotorno, N, Finegan, E, Sampedro, F, Caso, F. Editorial: Genotype-phenotype correlations in neurodegenerative diseases: From clinical features to neuroimaging signatures. Frontiers in Neurology. 2022; 13DOI:10.3389/fneur.2022.1100953. PMID:36588898. IF:3.400(Q2/5D).